QL1706

Clinical trials for QL1706 explained in plain language.

Never miss a new study

Get alerted when new QL1706 trials appear

Sign up with your email to follow new studies for QL1706, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

Triple-Threat attack on tough liver cancer

Disease control Recruiting now

This study is testing a new three-part treatment for people with advanced liver cancer that has spread into a major vein in the liver. The treatment combines immunotherapy, a targeted drug, and chemotherapy delivered directly to the liver. The main goal is to see if this combinat…

Matched conditions: QL1706

Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

QL1706

Get alerted when new QL1706 trials appear

Triple-Threat attack on tough liver cancer